The protective effect of an interferon inducer with a low molecular weight, 9- methylstreptimidone (9-MS), against Candida albicans infection in mice was investigated. The antibiotic was effective only when given prophylactically. When administered in such a manner, the growth of C. albicans in the kidneys and brain was inhibited at the initial stage of infection. The growth of C. albicans was not inhibited by the antibiotic in vitro, and no antifungal effect was obtained in a preparation containing induced interferon. These results suggest that the antifungal action of 9-methylstreptimidone in mice might be manifested not by direct antifungal activity but rather by a host-mediated activity that excludes interferon-inducing capability.
Several well-known interferon inducers inhibit growth of spontaneous or transplanted tumors in mice (3, 7, 24) , DNA synthesis in HeLa cells (21) , and lymphocyte transformation induced by phytohemagglutinin (8) and enhance antibody formation in mice (1, 2, 16) . These inducers inhibit growth of infectious agents other than viruses in vivo. Included are Chlamydia (9) , protozoa (4, 5, 19) , Rickettsia (6) , and bacteria (10, 11, 12, 23) . Specifically, polyinosinic-polycytidylic acid and statolon (4, 5) inhibit growth of Plasmodium berghei and Leishmania donovani m mice.
Several polyanionic interferon inducers (10, 23) have been proven effective against experimental infections in mice caused by Escherichia coli, Klebsiella pneumoniae, Listeria monocytogenes, and various gram-positive bacteria. The report of Regelson and Munson (11) suggests that the pyran copolymer is active against infection with Cryptococcus neoformans in mice.
The present report shows evidence that mice treated with an interferon inducer, 9-methylstreptimidone [9- S, S, S, S 0 9, 9, 9, 9, 9, 9, 9, 9, 9, 9, 10, 10, (-24, -3, and -1 h) , twice after infection (1 and 3 h), and twice daily for 8 consecutive days after C. albicans infection. Whereas all the control mice died within 13 days of infection, 5% of the mice that received interferon i.m. and 14% of those that received interferon i.p. survived (Table 3 ). This protective effect was not considered to be statistically significant.
Though exogenous interferon did not indicate any protective effect on C. albicans infection in mice, the interferon inducer 9-MS gave significant protection. Therefore the major effect of 9-MS against C. albicans infection may not be due to interferon induced by the antibiotic.
Direct effects of 9-MS and interferon on growth of C. albicans. The effects of 9-MS and interferon on C. albicans growth in vitro were examined. One milliliter of 9-MS (2 mg/ ml) or interferon (1 x 105 U/ml), each dissolved in Sabouraud broth, was added to 1 ml of the same medium containing 4 x 102 C. albicans cells, and the total yield of C. albicans was assayed after 6, 12, and 24 h of incubation by colony counting. No differences were observed among the groups treated with 9-MS or interferon and the nontreated control. DISCUSSION 9-MS has antiviral activity. It inhibits the growth of poliovirus, vesicular stomatitis virus, and Newcastle disease virus in vitro and is effective in prolonging the life of mice infected with 4,5,5,5,7,7,8,8,8,8,9,9,9, influenza virus (20) . Although 9-MS stimulates interferon production in mouse lung cells and serum (14, 20) , the mechanism of the protective action of 9-MS on influenza-infected mice has not been completely characterized. Whereas the protective effect of 9-MS against influenza virus infection in vivo is obtained with a nontoxic dose, it inhibits growth of influenza virus in vitro only when present at almost cytotoxic concentrations. These observations suggest that the protective effect of 9-MS on influenza infection might be due to interferon. When 9-MS was administered before inoculation of mice with C. albicans, it effected a reproducible increase in survival times and cure rate (Tables 1 and 2 ). When administered after inoculation, 9-MS was not effective (Table 2) . Prophylactic administration of 9-MS clearly inhibited the growth of C. albicans in kidney and brain at the initial stage of infection (Fig. 1) .
The growth of C. albicans in Sabouraud broth was not inhibited by 1 mg of 9-MS per ml.
These results suggest that the antifungal effect of 9-MS in mice might be due to enhancement of the immune response and interferon induction rather than direct antifungal activity. However, exogenous interferon had no inhibitory activity on Candida infections in mice (Table 3). Therefore it appears that the interferon induced by the antibiotic is not involved in the protective effect of 9-MS.
The present study indicates but does not prove that the protective effect of 9-MS on C. albicans infection is mediated by the host's nonspecific defense mechanisms. One possibility is that macrophages are activated, and this is currently under study (17, 18) .
